https://european-biotechnology.net/wp-content/uploads/2024/09/Individor-e1725432031394-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-04 06:41:252024-09-04 06:41:25Individor set to waive AEF0117 licence after Phase IIb failure
https://european-biotechnology.net/wp-content/uploads/2024/09/Nxteras-London-site-e1725271175184.jpg
450
800
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-02 10:00:072024-09-02 10:00:07Nxera Pharma Ltd collects clinical US$35m milestone
https://european-biotechnology.net/wp-content/uploads/2024/08/ML.jpng_-1030x803-1.png
803
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-29 05:29:472024-08-29 05:29:47Researchers present AI-guided protein design tool
https://european-biotechnology.net/wp-content/uploads/2024/08/Amferia-plaster-1030x542-1.jpg
542
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-27 12:48:422024-08-27 12:48:42Amferia partners with Biokema expanding into Switzerland
https://european-biotechnology.net/wp-content/uploads/2024/08/Veronica-Sanin-1030x630-1.png
630
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-27 11:46:352024-08-27 11:46:35Confusion in Germany about useful genetic testing
https://european-biotechnology.net/wp-content/uploads/2024/08/EXXON-1030x686-1.png
686
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-23 07:59:492024-08-23 07:59:49AI identifies most effective climate policies
https://european-biotechnology.net/wp-content/uploads/2024/08/Biopole-SA-1030x373-1.jpg
373
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-21 06:58:372024-08-21 06:58:37Vandria closes Series A round at CHF28.3m
https://european-biotechnology.net/wp-content/uploads/2024/08/ADCendo_Gilde-e1724144324670-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-20 08:59:302024-08-20 08:59:30Adcendo broadens ADC pipeline in US$1bn biobucks deal
https://european-biotechnology.net/wp-content/uploads/2024/08/Emfret-1030x390-1.png
390
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-20 07:44:542024-08-20 07:44:54Emfret presents novel anticoagulant
https://european-biotechnology.net/wp-content/uploads/2024/08/BioNtechMedilink.png
356
765
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-08-19 11:58:592024-08-19 11:58:59BioNTech: ADC study continues with conditions
Scroll to top
